img

Global and India Biopharmaceutical CDMO Service Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and India Biopharmaceutical CDMO Service Market Report & Forecast 2024-2034

The global Biopharmaceutical CDMO Service revenue was US$ 14640 million in 2022 and is forecast to a readjusted size of US$ 29770 million by 2033 with a CAGR of 10.3% during the review period (2023-2033).
In India, the Biopharmaceutical CDMO Service revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Biopharmaceutical CDMO Service include KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma and Catalent, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Biopharmaceutical CDMO Service market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Biopharmaceutical CDMO Service will continue to grow rapidly in the future.
Global Biopharmaceutical CDMO Service Scope and Market Size
Biopharmaceutical CDMO Service market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biopharmaceutical CDMO Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Biopharmaceutical CDMO Service market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.



By Company


KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Segment by Type
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others

Segment by Application


Pharmaceutical Company
Biotechnology Company
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Biopharmaceutical CDMO Service definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Biopharmaceutical CDMO Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Biopharmaceutical CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical CDMO Service revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Biopharmaceutical CDMO Service Product Introduction
1.2 Global Biopharmaceutical CDMO Service Outlook 2018 VS 2022 VS 2033
1.2.1 Global Biopharmaceutical CDMO Service Market Size for the Year 2018-2033
1.2.2 India Biopharmaceutical CDMO Service Market Size for the Year 2018-2033
1.3 Biopharmaceutical CDMO Service Market Size, India VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of India Biopharmaceutical CDMO Service in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Biopharmaceutical CDMO Service Market Size, India VS Global, 2018 VS 2022 VS 2033
1.4 Biopharmaceutical CDMO Service Market Dynamics
1.4.1 Biopharmaceutical CDMO Service Industry Trends
1.4.2 Biopharmaceutical CDMO Service Market Drivers
1.4.3 Biopharmaceutical CDMO Service Market Challenges
1.4.4 Biopharmaceutical CDMO Service Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Biopharmaceutical CDMO Service by Type
2.1 Biopharmaceutical CDMO Service Market Segment by Type
2.1.1 Develop Innovative Drugs
2.1.2 Listed Patented Drug
2.1.3 Biosimilars
2.1.4 Others
2.2 Global Biopharmaceutical CDMO Service Market Size by Type (2018, 2022 & 2033)
2.3 Global Biopharmaceutical CDMO Service Market Size by Type (2018-2033)
2.4 India Biopharmaceutical CDMO Service Market Size by Type (2018, 2022 & 2033)
2.5 India Biopharmaceutical CDMO Service Market Size by Type (2018-2033)
3 Biopharmaceutical CDMO Service by Application
3.1 Biopharmaceutical CDMO Service Market Segment by Application
3.1.1 Pharmaceutical Company
3.1.2 Biotechnology Company
3.1.3 Others
3.2 Global Biopharmaceutical CDMO Service Market Size by Application (2018, 2022 & 2033)
3.3 Global Biopharmaceutical CDMO Service Market Size by Application (2018-2033)
3.4 India Biopharmaceutical CDMO Service Market Size by Application (2018, 2022 & 2033)
3.5 India Biopharmaceutical CDMO Service Market Size by Application (2018-2033)
4 Global Biopharmaceutical CDMO Service Competitor Landscape by Company
4.1 Global Biopharmaceutical CDMO Service Market Size by Company
4.1.1 Global Key Companies of Biopharmaceutical CDMO Service, Ranked by Revenue (2022)
4.1.2 Global Biopharmaceutical CDMO Service Revenue by Player (2018-2023)
4.2 Global Biopharmaceutical CDMO Service Concentration Ratio (CR)
4.2.1 Biopharmaceutical CDMO Service Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biopharmaceutical CDMO Service in 2022
4.2.3 Global Biopharmaceutical CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Biopharmaceutical CDMO Service Head office and Area Served
4.4 Global Key Players of Biopharmaceutical CDMO Service, Product and Application
4.5 Global Key Players of Biopharmaceutical CDMO Service, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Biopharmaceutical CDMO Service Market Size by Company
4.7.1 Key Players of Biopharmaceutical CDMO Service in India, Ranked by Revenue (2022)
4.7.2 India Biopharmaceutical CDMO Service Revenue by Players (2021, 2022 & 2023)
5 Global Biopharmaceutical CDMO Service Market Size by Region
5.1 Global Biopharmaceutical CDMO Service Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Biopharmaceutical CDMO Service Market Size by Region (2018-2033)
5.2.1 Global Biopharmaceutical CDMO Service Market Size by Region: 2018-2023
5.2.2 Global Biopharmaceutical CDMO Service Market Size by Region (2024-2033)
6 Americas
6.1 Americas Biopharmaceutical CDMO Service Market Size YoY Growth 2018-2033
6.2 Americas Biopharmaceutical CDMO Service Market Size by Type
6.2.1 Americas Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
6.2.2 Americas Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
6.2.3 Americas Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
6.3 Americas Biopharmaceutical CDMO Service Market Size by Application
6.3.1 Americas Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
6.3.2 Americas Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
6.3.3 Americas Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
6.4 Americas Biopharmaceutical CDMO Service Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Biopharmaceutical CDMO Service Market Size YoY Growth 2018-2033
7.2 EMEA Biopharmaceutical CDMO Service Market Size by Type
7.2.1 EMEA Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
7.2.2 EMEA Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
7.2.3 EMEA Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
7.3 EMEA Biopharmaceutical CDMO Service Market Size by Application
7.3.1 EMEA Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
7.3.2 EMEA Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
7.3.3 EMEA Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
7.4 EMEA Biopharmaceutical CDMO Service Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Biopharmaceutical CDMO Service Market Size YoY Growth 2018-2033
8.2 China Biopharmaceutical CDMO Service Market Size by Type
8.2.1 China Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
8.2.2 China Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
8.2.3 China Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
8.3 China Biopharmaceutical CDMO Service Market Size by Application
8.3.1 China Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
8.3.2 China Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
8.3.3 China Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Biopharmaceutical CDMO Service Market Size YoY Growth 2018-2033
9.2 APAC Biopharmaceutical CDMO Service Market Size by Type
9.2.1 APAC Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
9.2.2 APAC Biopharmaceutical CDMO Service Market Size by Type (2024-2033)
9.2.3 APAC Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
9.3 APAC Biopharmaceutical CDMO Service Market Size by Application
9.3.1 APAC Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
9.3.2 APAC Biopharmaceutical CDMO Service Market Size by Application (2024-2033)
9.3.3 APAC Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
9.4 APAC Biopharmaceutical CDMO Service Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 KBI Biopharma
10.1.1 KBI Biopharma Company Details
10.1.2 KBI Biopharma Business Overview
10.1.3 KBI Biopharma Biopharmaceutical CDMO Service Introduction
10.1.4 KBI Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.1.5 KBI Biopharma Recent Development
10.2 INCOG BioPharma Services
10.2.1 INCOG BioPharma Services Company Details
10.2.2 INCOG BioPharma Services Business Overview
10.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Introduction
10.2.4 INCOG BioPharma Services Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.2.5 INCOG BioPharma Services Recent Development
10.3 CordenPharma
10.3.1 CordenPharma Company Details
10.3.2 CordenPharma Business Overview
10.3.3 CordenPharma Biopharmaceutical CDMO Service Introduction
10.3.4 CordenPharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.3.5 CordenPharma Recent Development
10.4 AGC Biologics
10.4.1 AGC Biologics Company Details
10.4.2 AGC Biologics Business Overview
10.4.3 AGC Biologics Biopharmaceutical CDMO Service Introduction
10.4.4 AGC Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.4.5 AGC Biologics Recent Development
10.5 Northway Biotech
10.5.1 Northway Biotech Company Details
10.5.2 Northway Biotech Business Overview
10.5.3 Northway Biotech Biopharmaceutical CDMO Service Introduction
10.5.4 Northway Biotech Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.5.5 Northway Biotech Recent Development
10.6 PlantForm Corp
10.6.1 PlantForm Corp Company Details
10.6.2 PlantForm Corp Business Overview
10.6.3 PlantForm Corp Biopharmaceutical CDMO Service Introduction
10.6.4 PlantForm Corp Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.6.5 PlantForm Corp Recent Development
10.7 Lonza
10.7.1 Lonza Company Details
10.7.2 Lonza Business Overview
10.7.3 Lonza Biopharmaceutical CDMO Service Introduction
10.7.4 Lonza Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.7.5 Lonza Recent Development
10.8 ADL Biopharma
10.8.1 ADL Biopharma Company Details
10.8.2 ADL Biopharma Business Overview
10.8.3 ADL Biopharma Biopharmaceutical CDMO Service Introduction
10.8.4 ADL Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.8.5 ADL Biopharma Recent Development
10.9 Catalent
10.9.1 Catalent Company Details
10.9.2 Catalent Business Overview
10.9.3 Catalent Biopharmaceutical CDMO Service Introduction
10.9.4 Catalent Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.9.5 Catalent Recent Development
10.10 Future Fields
10.10.1 Future Fields Company Details
10.10.2 Future Fields Business Overview
10.10.3 Future Fields Biopharmaceutical CDMO Service Introduction
10.10.4 Future Fields Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.10.5 Future Fields Recent Development
10.11 Vetter Pharma
10.11.1 Vetter Pharma Company Details
10.11.2 Vetter Pharma Business Overview
10.11.3 Vetter Pharma Biopharmaceutical CDMO Service Introduction
10.11.4 Vetter Pharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.11.5 Vetter Pharma Recent Development
10.12 Stelis
10.12.1 Stelis Company Details
10.12.2 Stelis Business Overview
10.12.3 Stelis Biopharmaceutical CDMO Service Introduction
10.12.4 Stelis Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.12.5 Stelis Recent Development
10.13 Richter-Helm
10.13.1 Richter-Helm Company Details
10.13.2 Richter-Helm Business Overview
10.13.3 Richter-Helm Biopharmaceutical CDMO Service Introduction
10.13.4 Richter-Helm Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.13.5 Richter-Helm Recent Development
10.14 FUJIFILM Diosynth Biotechnologies
10.14.1 FUJIFILM Diosynth Biotechnologies Company Details
10.14.2 FUJIFILM Diosynth Biotechnologies Business Overview
10.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Introduction
10.14.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.14.5 FUJIFILM Diosynth Biotechnologies Recent Development
10.15 Cambrex
10.15.1 Cambrex Company Details
10.15.2 Cambrex Business Overview
10.15.3 Cambrex Biopharmaceutical CDMO Service Introduction
10.15.4 Cambrex Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.15.5 Cambrex Recent Development
10.16 Pfizer CentreOne
10.16.1 Pfizer CentreOne Company Details
10.16.2 Pfizer CentreOne Business Overview
10.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Introduction
10.16.4 Pfizer CentreOne Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.16.5 Pfizer CentreOne Recent Development
10.17 Samsung Biologics
10.17.1 Samsung Biologics Company Details
10.17.2 Samsung Biologics Business Overview
10.17.3 Samsung Biologics Biopharmaceutical CDMO Service Introduction
10.17.4 Samsung Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023)
10.17.5 Samsung Biologics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Biopharmaceutical CDMO Service Market Size India VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Biopharmaceutical CDMO Service Market Trends
Table 3. Biopharmaceutical CDMO Service Market Drivers
Table 4. Biopharmaceutical CDMO Service Market Challenges
Table 5. Biopharmaceutical CDMO Service Market Restraints
Table 6. Global Biopharmaceutical CDMO Service Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. India Biopharmaceutical CDMO Service Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Biopharmaceutical CDMO Service Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. India Biopharmaceutical CDMO Service Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Biopharmaceutical CDMO Service, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Biopharmaceutical CDMO Service Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Biopharmaceutical CDMO Service Revenue Share by Player, 2018-2023
Table 13. Global Biopharmaceutical CDMO Service Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biopharmaceutical CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO Service as of 2022)
Table 15. Global Key Players of Biopharmaceutical CDMO Service, Headquarters and Area Served
Table 16. Global Key Players of Biopharmaceutical CDMO Service, Product and Application
Table 17. Global Key Players of Biopharmaceutical CDMO Service, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Biopharmaceutical CDMO Service in India, Ranked by Revenue (2022) & (US$ Million)
Table 20. India Biopharmaceutical CDMO Service Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. India Biopharmaceutical CDMO Service Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Biopharmaceutical CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Biopharmaceutical CDMO Service Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Biopharmaceutical CDMO Service Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Biopharmaceutical CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Biopharmaceutical CDMO Service Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Biopharmaceutical CDMO Service Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Biopharmaceutical CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Biopharmaceutical CDMO Service Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Biopharmaceutical CDMO Service Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Biopharmaceutical CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Biopharmaceutical CDMO Service Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Biopharmaceutical CDMO Service Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Biopharmaceutical CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Biopharmaceutical CDMO Service Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Biopharmaceutical CDMO Service Market Size by Region (2024-2033) & (US$ Million)
Table 51. KBI Biopharma Company Details
Table 52. KBI Biopharma Business Overview
Table 53. KBI Biopharma Biopharmaceutical CDMO Service Product
Table 54. KBI Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 55. KBI Biopharma Recent Development
Table 56. INCOG BioPharma Services Company Details
Table 57. INCOG BioPharma Services Business Overview
Table 58. INCOG BioPharma Services Biopharmaceutical CDMO Service Product
Table 59. INCOG BioPharma Services Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 60. INCOG BioPharma Services Recent Development
Table 61. CordenPharma Company Details
Table 62. CordenPharma Business Overview
Table 63. CordenPharma Biopharmaceutical CDMO Service Product
Table 64. CordenPharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 65. CordenPharma Recent Development
Table 66. AGC Biologics Company Details
Table 67. AGC Biologics Business Overview
Table 68. AGC Biologics Biopharmaceutical CDMO Service Product
Table 69. AGC Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 70. AGC Biologics Recent Development
Table 71. Northway Biotech Company Details
Table 72. Northway Biotech Business Overview
Table 73. Northway Biotech Biopharmaceutical CDMO Service Product
Table 74. Northway Biotech Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 75. Northway Biotech Recent Development
Table 76. PlantForm Corp Company Details
Table 77. PlantForm Corp Business Overview
Table 78. PlantForm Corp Biopharmaceutical CDMO Service Product
Table 79. PlantForm Corp Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 80. PlantForm Corp Recent Development
Table 81. Lonza Company Details
Table 82. Lonza Business Overview
Table 83. Lonza Biopharmaceutical CDMO Service Product
Table 84. Lonza Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 85. Lonza Recent Development
Table 86. ADL Biopharma Company Details
Table 87. ADL Biopharma Business Overview
Table 88. ADL Biopharma Biopharmaceutical CDMO Service Product
Table 89. ADL Biopharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 90. ADL Biopharma Recent Development
Table 91. Catalent Company Details
Table 92. Catalent Business Overview
Table 93. Catalent Biopharmaceutical CDMO Service Product
Table 94. Catalent Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 95. Catalent Recent Development
Table 96. Future Fields Company Details
Table 97. Future Fields Business Overview
Table 98. Future Fields Biopharmaceutical CDMO Service Product
Table 99. Future Fields Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 100. Future Fields Recent Development
Table 101. Vetter Pharma Company Details
Table 102. Vetter Pharma Business Overview
Table 103. Vetter Pharma Biopharmaceutical CDMO Service Product
Table 104. Vetter Pharma Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 105. Vetter Pharma Recent Development
Table 106. Stelis Company Details
Table 107. Stelis Business Overview
Table 108. Stelis Biopharmaceutical CDMO Service Product
Table 109. Stelis Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 110. Stelis Recent Development
Table 111. Richter-Helm Company Details
Table 112. Richter-Helm Business Overview
Table 113. Richter-Helm Biopharmaceutical CDMO Service Product
Table 114. Richter-Helm Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 115. Richter-Helm Recent Development
Table 116. FUJIFILM Diosynth Biotechnologies Company Details
Table 117. FUJIFILM Diosynth Biotechnologies Business Overview
Table 118. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product
Table 119. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 120. FUJIFILM Diosynth Biotechnologies Recent Development
Table 121. Cambrex Company Details
Table 122. Cambrex Business Overview
Table 123. Cambrex Biopharmaceutical CDMO Service Product
Table 124. Cambrex Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 125. Cambrex Recent Development
Table 126. Pfizer CentreOne Company Details
Table 127. Pfizer CentreOne Business Overview
Table 128. Pfizer CentreOne Biopharmaceutical CDMO Service Product
Table 129. Pfizer CentreOne Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 130. Pfizer CentreOne Recent Development
Table 131. Samsung Biologics Company Details
Table 132. Samsung Biologics Business Overview
Table 133. Samsung Biologics Biopharmaceutical CDMO Service Product
Table 134. Samsung Biologics Revenue in Biopharmaceutical CDMO Service Business (2018-2023) & (US$ Million)
Table 135. Samsung Biologics Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceutical CDMO Service Product Picture
Figure 2. Global Biopharmaceutical CDMO Service Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Biopharmaceutical CDMO Service Market Size 2018-2033 (US$ Million)
Figure 4. India Biopharmaceutical CDMO Service Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. India Biopharmaceutical CDMO Service Market Size 2018-2033 (US$ Million)
Figure 6. India Biopharmaceutical CDMO Service Market Share in Global 2018-2033
Figure 7. Biopharmaceutical CDMO Service Report Years Considered
Figure 8. Product Picture of Develop Innovative Drugs
Figure 9. Product Picture of Listed Patented Drug
Figure 10. Product Picture of Biosimilars
Figure 11. Product Picture of Others
Figure 12. Global Biopharmaceutical CDMO Service Market Share by Type in 2022 & 2033
Figure 13. Global Biopharmaceutical CDMO Service Market Size by Type (2018-2033) & (US$ Million)
Figure 14. Global Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 15. India Biopharmaceutical CDMO Service Market Share by Type in 2022 & 2033
Figure 16. India Biopharmaceutical CDMO Service Market Size by Type (2018-2033) & (US$ Million)
Figure 17. India Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 18. Product Picture of Pharmaceutical Company
Figure 19. Product Picture of Biotechnology Company
Figure 20. Product Picture of Others
Figure 21. Global Biopharmaceutical CDMO Service Market Share by Application in 2022 & 2033
Figure 22. Global Biopharmaceutical CDMO Service Market Size by Application (2018-2033) & (US$ Million)
Figure 23. Global Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 24. India Biopharmaceutical CDMO Service Market Share by Application in 2022 & 2033
Figure 25. India Biopharmaceutical CDMO Service Market Size by Application (2018-2033) & (US$ Million)
Figure 26. India Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 27. The Top 5 and 10 Largest Companies of Biopharmaceutical CDMO Service in the World: Market Share by Biopharmaceutical CDMO Service Revenue in 2022
Figure 28. Global Biopharmaceutical CDMO Service Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 29. Global Biopharmaceutical CDMO Service Market Share by Region (2018-2033)
Figure 30. Americas Biopharmaceutical CDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 31. Americas Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 32. Americas Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 33. United States Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Canada Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Mexico Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Brazil Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. EMEA Biopharmaceutical CDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 38. EMEA Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 39. EMEA Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 40. Europe Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Middle East Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Africa Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Biopharmaceutical CDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 44. China Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 45. China Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 46. APAC Biopharmaceutical CDMO Service Market Size Growth Rate 2018-2033 (US$ Million)
Figure 47. APAC Biopharmaceutical CDMO Service Market Share by Type (2018-2033)
Figure 48. APAC Biopharmaceutical CDMO Service Market Share by Application (2018-2033)
Figure 49. Japan Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. South Korea Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. China Taiwan Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. India Biopharmaceutical CDMO Service Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 55. INCOG BioPharma Services Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 56. CordenPharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 57. AGC Biologics Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 58. Northway Biotech Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 59. PlantForm Corp Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 60. Lonza Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 61. ADL Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 62. Catalent Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 63. Future Fields Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 64. Vetter Pharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 65. Stelis Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 66. Richter-Helm Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 67. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 68. Cambrex Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 69. Pfizer CentreOne Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 70. Samsung Biologics Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries